(PIP:Consolidated issues listed on NYSE MKT LLC)
Mitchel B. Sayare Ph.D.
Chairman of The Board, Chairman of Audit Committee, Member of Governance & Nominating Committee and Member of Compensation Committee, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 19 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Mitchel B. Sayare, also known as Mitch, Ph.D. served as the Chief Executive Officer of ImmunoGen Inc. (a biotechnology company) from 1986 to January 1, 2009 and as its President from 1994 to July 29, 2008. From 1986 to 1992, Dr. Sayare served as the President of ImmunoGen Inc. From 1982 to 1985, Dr. Sayare served as a Vice President of Development at Xenogen Inc. Dr. Sayare has been the Chairman of PharmAthene, Inc. since July 15, 2011. Dr. Sayare served as the Chairman ...
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Chairman of The Board, Chairman of Audit Committee, Member of Governance & Nominating Committee and Member of Compensation Committee
Temple University School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|M. Michelle Berrey M.D., MPH.||Chief Executive Officer, President, Chief Medical Officer and Director|
|Paul Chaplin MSc, Ph.D.||Chief Executive Officer and President|
Bavarian Nordic A/S
|Anthony S. Marucci M.B.A.||Founder, Chief Executive Officer, President and Director|
Celldex Therapeutics, Inc.
|Peter Mørch Eriksen BBA||Chief Executive Officer and Administration Director|
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|